Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 160.001 mg - tablet - excipient ingredients: magnesium stearate; silicon dioxide; purified talc; iron oxide yellow; iron oxide red; powdered cellulose; hypromellose; macrogol 8000; calcium hydrogen phosphate; hyprolose; croscarmellose sodium; aluminium magnesium silicate; purified water; titanium dioxide - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 320.001 mg - tablet - excipient ingredients: magnesium stearate; macrogol 8000; powdered cellulose; croscarmellose sodium; hypromellose; aluminium magnesium silicate; silicon dioxide; iron oxide yellow; hyprolose; purified talc; titanium dioxide; purified water; calcium hydrogen phosphate - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - amlodipine besilate, quantity: 13.87 mg; perindopril arginine, quantity: 5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; lactose monohydrate - apx-perindopril arginine/ amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 160 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; crospovidone; hypromellose; purified talc; macrogol 4000; iron oxide red; iron oxide yellow; titanium dioxide - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); valsartan, quantity: 160 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; crospovidone; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; macrogol 4000; iron oxide yellow - exforge hct is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).

Австралия - английский - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 320 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; magnesium stearate; iron oxide yellow; crospovidone; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; macrogol 4000 - exforge is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Соединенные Штаты - английский - NLM (National Library of Medicine)

sandoz inc - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288), valsartan (unii: 80m03yxj7i) (valsartan - unii:80m03yxj7i) - amlodipine 5 mg - amlodipine and valsartan tablets may be used in patients whose blood pressure is not adequately controlled on either monotherapy. amlodipine and valsartan tablets may also be used as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals. the choice of amlodipine and valsartan tablets as initial therapy for hypertension should be based on an assessment of potential benefits and risks including whether the patient is likely to tolerate the lowest dose of amlodipine and valsartan tablets. patients with stage 2 hypertension (moderate or severe) are at a relatively higher risk for cardiovascular events (such as strokes, heart attacks, and heart failure), kidney failure and vision problems, so prompt treatment is clinically relevant. the decision to use a combination as initial therapy should be individualized and should be shaped by considerations such as baseline blood pressure, the target goal and the incremental likelihood of achieving goal with a combination co

Бельгия - английский - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apotex europe b.v. - amlodipine besilate 6,935 mg - eq. amlodipine 5 mg; valsartan 80 mg - film-coated tablet - 5 mg - 80 mg - amlodipine besilate 6.935 mg; valsartan 80 mg - valsartan and amlodipine

Бельгия - английский - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apotex europe b.v. - amlodipine besilate 6,935 mg - eq. amlodipine 5 mg; valsartan 160 mg - film-coated tablet - 5 mg - 160 mg - amlodipine besilate 6.935 mg; valsartan 160 mg - valsartan and amlodipine

Бельгия - английский - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apotex europe b.v. - amlodipine besilate 13,87 mg - eq. amlodipine 10 mg; valsartan 160 mg - film-coated tablet - 10 mg - 160 mg - amlodipine besilate 13.87 mg; valsartan 160 mg - valsartan and amlodipine